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In this study, the effects of geraniin on osteoprotegerin/receptor activator of nuclear factor-κB ligand(OPG/
RANKL) in regulating the proliferation of osteoblasts and suppression of osteoclast-like cells (OLC) in 
OLC-osteoblast co-cultured system in vitro were investigated. Osteoblasts were cultured and identified 
with alkaline phosphatase (ALP), gomori stain, and mineralized nodule stain. OLCs were isolated from 
long bones of Sprague–Dawley (SD) rats and identified with tartrate-resistant acid phosphatase(TRAP) 
stain. Methyl thiazolyl tetrazolium assay was used to examine the proliferation of osteoblasts, and 
immunocytochemistry and in situ hybridization to analyze the expression OPG/RANKL in osteoblasts 
co-cultured with osteoclasts under the action of geraniin, respectively. Geraniin could regulate the 
proliferation of osteoblasts MC3T3-E1, decrease the number of OLC in OLC-osteoblast co-cultured 
system, and inhibit the bone resorption areas and resorption pits of OLC in vitro experiments. Geraniin 
could promote the mRNA and protein expression levels of OPG and suppress those of RANKL in 
osteoblasts. These results indicate that geraniin has a promoting effect on the proliferation of osteoblasts 
and an inhibitory effect on the osteoclastic bone-resorption through regulating OPG/RANKL signaling 
pathway in OLC-OB co-cultured system.
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INTRODUCTION
Bone morphogenesis and remodeling involve the 
bone formation from osteoblasts (OB) and the bone 
resorption by osteoclasts (OC). As an in vitro model 
of osteoblast differentiation, MC3T3-E1 cell line, 
derived from newborn murine calvariae and exhibiting a 
developmental sequence similar to primary osteoblasts, 
has been examined extensively, and can be identified 
with hematoxylin and eosin (HE), ALP, Gomori, and 
mineralized nodules Von Kossa staining, and thus is 
widely used as to a cytochemical marker that identifies 
osteoblasts in tissue sections as well as in cell cultures 
(Ryoo et al., 1997; Lee, Choi, 2011; Kim et al., 2012; Luan 
et al., 2012; Czekanska et al., 2014). TRAP, a widely used 
cytochemical marker, can identify osteoclasts and their 
precursors. OLC can be induced from mouse monocyte/
macrophage RAW264.7 that expresses TRAP (Denlinger 
et al., 1996; Janckila, Yam, 2009).
OPG and RANKL are the important members of 
tumor necrosis factor (TNF) family found in recent years. 
OPG is a new open reading frame and encoding a protein 
with 401 amino acid residues discovered in the analysis 
of fetal rat intestinal cDNA sequencing by Simonet et al. 
(1997). OPG is thought to inhibit osteoclastogenesis by 
disrupting the cell-to-cell signaling between osteoblastic 
stromal cells and osteoclast progenitors. RANKL is a type 
II transmembrane protein, and highly expressed in bone 
and bone marrow. The findings of OPG and RANKL as 
well as the transgenic characteristics and gene-knockout 
animals indicate that the cytokine system is the necessary 
factor for osteoclastic biology (Kiechl et al., 2006). 
Geraniin, extracted and separated from the aerial 
parts of Phyllanthus amarus Linn (Euphorbiaceae), has 
been found to possess a wide range of biological activities 
including antioxidation and free radical scavenging (Ito, 
X. Zhang, R. Yang, J. Long, B. He, Y. Zhang, T. Fu, Z. Shen, P. Chen
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2011), antinociceptive (Kupeli et al., 2007), and antivirus 
activities (Yang et al., 2012). In the previous experiments, 
we found that geraniin showed a preventive effect in rat 
models of tretinoin-induced osteoporosis, and inhibited 
bone resorption in vitro by down-regulating the mRNA 
and protein expression of matrix metalloproteinase-9 
(MMP-9) in rat osteoclasts (He et al., 2013). However, 
whether geraniin exhibits an inhibitory effect on bone 
resorption induced by OLC or modulates OPG/RANKL 
signal transduction pathway in osteoblasts is not yet known. 
In this study, we investigated the effect of geraniin on OLC-
induced bone resorption in vitro and the mRNA and protein 
expression of OPG and RANKL in rat osteoblasts.
MATERIAL AND METHODS
Animals 
All the animal experiments were approved by the 
Animal Study Committee of Kunming Medical University 
and were conducted according to the requirements of NIH 
Guidelines for care and use of laboratory animals. Specific 
pathogen free (SPF) level, SD rats aged one day, male 
and female, were purchased from the Animal Center of 
Kunming Medical University [License: SCXK (Yunnan) 
2015-0002].
Drugs and reagents 
Geraniin was extracted and separated from the aerial 
parts of Phyllanthus amarus Linn (Euphorbiaceae) by 
Professor Ji-Kai Liu (Kunming Institute of Botany, the 
Chinese Academy of Sciences, P.R. China). The purity was 
99% and its sample was deposited at Kunming Institute 
of Botany, the Chinese Academy of Sciences, P.R. China. 
The chemical construction was shown in Figure1. The 
compound was dissolved in dimethyl sulfoxide (DMSO) 
and then diluted with phosphate-buffer saline (PBS) prior 
to use. The final concentration of geraniin was 0.1‰ 
in PBS, and 0.01‰ in DMSO, which is not toxic to 
osteoclasts or osteoblasts. Alendronate (purity 99%) was 
purchased from Langze Medical Science and Technology 
Company, Nanjing, P.R. China. The compound was 
dissolved in DMSO and then diluted with PBS prior to use. 
MC3T3-E1 Subclone 14 was purchased from Cell Bank of 
the Chinese Academy of Sciences, Shanghai, P.R. China. 
Mouse monocyte macrophage cell line (RAW264.7) was 
purchased from Kunming Institute of Zoology, the Chinese 
Academy of Sciences, Kunming, P.R. China. Bovine 
bone slices (10 ×10 mm thick) were purchased from West 
China Medical Center of Sichuan University, Chengdu, 
P.R. China. The immunocytochemical kit was purchased 
from Zhongshan Golden Bridge Biological Company, 
Beijing, P.R. China. OPG and RANKL mRNA kits were 
purchased from Boster Bioengineering Company, Wuhan, 
P.R. China. TRAP-staining kit was purchased from Sigma 
Chemical Co., St. Louis, MO, USA. HE staining kit and 
MTT cell proliferation and cytotoxicity detection kit 
were purchased from Beyotime Biotechnology Research 
Institute, Jiangsu, P.R. China. The mouse recombinant 
sRANKL and macrophage colony stimulating factor 
(M-CSF) were purchased from PeproTech Co., Princeton, 
NJ, USA. OPG rabbit-anti-mouse polyclonal antibody 
and RANKL goat-anti-mouse polyclonal antibody were 
purchased from Santa Cruz Biotechnology, INC. Dallas, 
TX, USA. Dulbecco’s modified eagle medium (DMEM) 
F-12 and high glucose medium were purchased from 
HyClone Laboratories Inc. Logan, UT, USA. All the other 
chemicals were of analytical grade and were purchased 
from local commercial suppliers.
Culture and identification of osteoblasts 
The detailed culture protocols of osteoblasts were 
carried out according to the manufacturer’s directions. 
Briefly, after thawing of MC3T3-E1, the cells with 
1 × 106/mL were inoculated in the culture bottle, with 
DMEM/F-12 (DMEM: F-12: FBS=9: 9: 2) as the medium, 
and the cells were cultured under a humidified atmosphere 
of 5% CO2 at 37 °C for 24 h to allow the osteoblasts to 
adhere to 24-well plate directly and began to count, then 
exchanged the cell culture medium and the remaining 
adherent cells on the plate were continuously cultured and 
counted for 7 d, respectively. 
The cultured osteoblasts were identified with an 
invert microscope, HE stain, alkaline phosphorase (ALP) 
stain, Gomori stain, and stain of mineralized nodule (Von 
Kossa), respectively. 
FIGURE 1 - Chemical structure of geraniin.
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Methyl thiazolyl tetrazolium assay 
The proliferation of osteoblasts was examined with 
methyl thiazolyl tetrazolium (MTT) in microplate reader 
(490 nm). Briefly, the cells of the fourth generation were 
cultured in 1 × 105 cell/mL on the 96-well culture plate 
with DMEM/F-12 medium for 24 h, and then incubated 
with the different concentrations of geraniin for 24 h, 
adding MTT reagent and DMSO, counted the number of 
cells and measured cell optical density (OD). Osteogenic 
MC3T3-E1 were divided into nine groups as follows 
(n = 6 per group): blank control group with the complete 
culture media (later referred to as Control); geraniin 
groups with 10-6, 10-7, 10-8, 10-9, 10-10, 10-11, and 10-12 mol/L 
of geraniin in osteoblasts (later referred to as Geraniin); 
positive control group with 10-8 mol/L of alendronate 
in osteoblasts (later referred to as Alendronate). The 
inhibitory rate of cell growth was calculated according to 
the following formula:
Inhibitory rate (%)=[(OD of blank control group 
(OD of drug-treated group) / OD of blank control 
group]×100
Isolation, culture condition and identification of 
osteoclasts 
Osteoclasts were isolated from the long bones of 
1-day-old SD rats. Briefly, SD rats were euthanized via 
cervical dislocation and their femora were separated. 
The long bones were dissected free of the adherent soft 
tissues and quickly minced with a scalpel blade in HEPES-
buffered medium 199 supplemented with 15% fetal 
calf serum, 100 U/mL benzyl penicillin, and 100 U/mL 
streptomycin. The long bones were homogenized gently, 
and the cell suspension was collected in a centrifuge tube. 
The cell suspension was allowed to settle for 10 s, before 
the supernatant was dropped onto the plastic substrate. 
This osteoclast-rich supernatant was collected again and 
filtered through 70-µm nylon filters.
The cells of RAW264.7 were cultured under a 
humidified atmosphere of 5% CO2 at 37 °C in DMEM 
supplemented with 50 U/mL benzyl penicillin, and 50 
U/mL streptomycin. After thawing of RAW264.7, the 
cells were cultured under a humidified atmosphere of 5% 
CO2 at 37 °C in HEPES-buffered DMEM with 15% fetal 
calf serum, 100 U/mL benzyl penicillin, and 100 U/mL 
streptomycin. 
The detailed protocols of TRAP were carried out 
according to the manufacturer’s directions. Briefly, after 
cultivation at 37 °C for 72 h, the cells were fixed with 2.5% 
glutaraldehyde solution for 10 min, washed thrice with 
deionized water, and then incubated in TRAP-staining 
solution for 50 min. The morphology and number of 
TRAP-positive cells of OC and OLC were then counted 
and observed by microscope(Olympus) in 4d, 7d, 12d, 
and 15d, respectively. The TRAP-positive cells possessing 
three or more nuclei were defined as mature osteoclasts 
(mOC), and TRAP-positive cells containing less than 
three nuclei were distinguished as pre-osteoclasts (pOC) 
(n = 4 per group). The fusion index (FI) was calculated 
as the percentage of the total number of mOC divided 
by the total number of TRAP-positive cells counted. 
The inhibitory rate of FI was calculated according to the 
following formula:
The inhibitory rate of FI (%) = [ (FI of blank 
control group (FI of drug-treated group) / FI of blank 
control group] ×100
Co-culture of osteoclasts with osteoblasts
The in vitro establishment of OLC-OB co-cultured 
system was to inoculate RAW264.7 to lower chambers of 
24-well suspension culture plate directly or bovine bone 
slices for culture together in DMEM medium with 100 
ng/mL RANKL, 100 ng/mL M- CSF, and 10-8 Vitamin D3 
(VD3), and changed medium once every 3 d. After 9 d of 
culture, 0.5 mL DMEM medium in the lower chambers 
was changed and cultured 0.5 mL of 1.0×105 cell/mL 
MC3T3-E1 with DMEM medium (without RANKL, M- 
CSF, or VD3) in the upper chambers under a humidified 
atmosphere of 5% CO2 at 37 ℃, and after 24 h, the different 
concentrations of geraniin and 10-8 mol/L alendronate were 
added into the lower chambers for 2 d. The upper chamber 
and the medium in the lower chambers were removed 
and washed twice with a pre-warmed PBS solution, fixed 
with 4% paraformaldehyde, washed with 0.25 mol/L 
NH4OH solution. The bone resorption was visualized by 
1% toluidine blue staining. The resorptive areas and pits 
were quantified using an Image Pro Plus analysis system; 
the regions were also observed by scanning electronic 
microscopy (SEM). OLC-OB were cultured and divided 
into seven groups as follows (n = 4 per group): OLC 
group; OLC-OB co-culture group without any added 
substances; geraniin groups with 10-8, 10-9, 10-10, and 
10-11 mol/L of geraniin in OLC-OB co-culture system; 
positive control group with 10-8 mol/L of alendronate in 
OLC-OB co-culture system.
The assay of bone resorption was based on the 
ability of isolated osteoclasts, OLC, and OLC-OB to 
absorb devitalized cortical bone in vitro (Ducy, Schinke, 
X. Zhang, R. Yang, J. Long, B. He, Y. Zhang, T. Fu, Z. Shen, P. Chen
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Karsenty, 2000; Teitelbaum, 2000). After 72 h of culture 
with osteoclasts, and 4 d, 7 d, 12 d, and 15 d of culture 
with OLC and OLC-OB, the bovine bone slices were 
removed and fixed with 4% paraformaldehyde solution 
for 10 min. After the adherent cells were removed by 
treating the bovine bone slices with 0.25 mol/L NH4OH 
solution, the resorption areas and pits were visualized as 
described above.
Immunocytochemical and in situ hybridization 
analysis 
Immunocytochemical and in situ hybridization 
analysis of OPG/RANKL was performed according to 
the kit’s specifications. The values of integral optical 
density [IOD, equivalent to area of staining × mean optical 
density (MOD)] and MOD of positive cells in the visual 
field were detected by using a graphic analysis system. 
The slices were coated with 0.1% poly-L-Lysine, and one 
slice placed in each well of 24-well plate. The cells were 
cultured in the 24-well plate with poly-L-Lysine-coated 
slices for 24 h. Briefly, the slices were washed thrice with 
PBS, fixed in 4% paraformaldehyde solution for 20-30 
min, then treated with the 0.5 % Triton X-100 for 20 
min and 3% H2O2 for 10 min to inactivate endogenous 
peroxidase, and closed with 5 % sheep serum for 10 min. 
The slices were incubated overnight with a 1:400 dilution 
of OPG rabbit anti mouse polyclonal antibody or RANKL 
goat anti mouse polyclonal antibody, and finally stained 
with DAB. Osteoblasts were cultured and divided into 
seven groups as above (n = 4 per group). PBS instead of 
the first antibody was used as the negative control. IOD 
and MOD of positively stained cells were examined as 
described above.
Statistical analysis
Data are expressed as mean ± standard deviation 
(S.D.). Statistical comparisons were made by analysis 
of variance (ANOVA) and Student’s t-test. Differences 
were considered statistically significant when P was less 
than 0.05.
RESULTS
Effects of geraniin on proliferation and 
differentiation of osteoblasts 
Compared with the control group, there was no 
significant difference between geraniin (10-7 and 10-8 
mol/L) groups (P > 0.05) (Figure 2). However, the 
OD values of osteoblasts in alendronate and geraniin 
(10-9 to 10-12 mol/L) groups were significantly higher 
(P < 0.01) than those in control group. Furthermore, 
10-6 mol/L geraniin markedly decreased the OD values 
(P < 0.05) compared with the control group. 10-11 and 
10-12 mol/L geraniin showed a similar potency compared 
with alendronate. As presented in Figure 3A, 3B, and 4, 
compared with the mechanical method (3 d), the numbers 
of mOC and pOC were significantly higher than those in 
the induction method (4 d) (P < 0.01), but lower than that 
in the induction method (7 d, 12 d, and 15 d, respectively) 
(P < 0.01). However, the numbers of mOC and pOC in the 
induction method (4 d) were significantly lower (P < 0.01) 
than those in the induction method (7 d, 12 d, and 15 d, 
respectively). The numbers of mOC and pOC in the 
induction method (7 d) were significantly lower (P < 0.01) 
than those in the induction method (12 d and 15 d). FI was 
different between the mechanical method group and the 
induction method groups. As shown in Figure 3C, induction 
method (4 d and 7 d) significantly reduced FI as compared 
with the mechanical method (3 d) (P < 0.05). Induction 
method (12 d and 15 d) increased FI as compared with the 
mechanical method (3 d) and induction method (4 d and 7 d) 
(P < 0.01). As shown in Figure 4, the cellular morphology of 
osteoblasts had obvious difference between the mechanical 
and inductive methods.
Effects of geraniin on bone resorption in OLC-OB 
co-culture system
The bone resorptive areas were significantly 
different between the control groups (OLC and OLC-OB 
co-culture) (P < 0.01) (Figure 5A). In OLC and OLC-OB 
co-culture system, the bone resorptive areas in alendronate 
and geraniin (10-8 to 10-10 mol/L) groups were significantly 
decreased (P < 0.01) than those of the control groups. 10-8 
mol/L geraniin and alendronate showed similar abilities 
to decrease the resoptive areas.
There was no significant difference in the number 
of bone resorptive pits between the control (OLC and 
OLC-OB co-culture) and 10-11 mol/L geraniin groups. 
Geraniin (10-8 and 10-9 mol/L) and alendronate significantly 
decreased the number of bone resorptive pits compared 
with control groups (P <0.01). 10-8 mol/L geraniin and 
alendronate also showed similar abilities to decrease the 
bone resorptive pits (Figure 5B).
Protein and mRNA expression of OPG and RANKL 
There was no significant difference in the MOD 
values in OPG positive cells between the control and 
A novel effect of geraniin on OPG/RANKL signaling in osteoblasts
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FIGURE 2 - Effects of geraniin on proliferation of osteoblasts. Values are mean ± S.D. (n =6) aP < 0.05, bP < 0.01 versus control 
group, cP < 0.05, dP < 0.01 versus alendronate group.
FIGURE 3 - Comparison of osteoclast differentiation between induction and mechanical procedure. (A) The numbers of pOC 
were significantly higher than those in the induction method (4 d), but lower than that in the induction method (7 d, 12 d, and 15 d, 
respectively). The numbers of pOC in the induction method (4 d) were significantly lower than those in the induction method 
(7 d, 12 d, and 15 d, respectively). The numbers of pOC in the induction method (7 d) were significantly lower than those in the 
induction method (12 d and 15 d). (B) The numbers of mOC were significantly higher than those in the induction method (4 d), but 
lower than that in the induction method (7 d, 12 d, and 15 d, respectively). However, the numbers of mOC in the induction method 
(4 d) were significantly lower than those in the induction method (7 d, 12 d, and 15 d, respectively). The numbers of mOC in the 
induction method (7 d) were significantly lower than those in the induction method (12 d and 15 d). (C) Induction method (4 d and 
7 d) groups reduced FI as compared with the mechanical method (3 d) group. Induction method (12 d and 15 d) groups increased 
FI as compared with the mechanical method (3 d) group and induction method (4 d and 7 d) groups. Values are mean ± S.D(n =4). 
aP < 0.05, bP < 0.01 versus mechanical for 3 d group, cP < 0.05 versus induction for 4 d group, dP < 0.01 versus induction for 7 d 
group.
X. Zhang, R. Yang, J. Long, B. He, Y. Zhang, T. Fu, Z. Shen, P. Chen
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geraniin (10-11 mol/L) groups (Figure 6A and Figure 8A). 
In comparison, geraniin (10-11 to10-8 mol/L) did increase 
IOD and MOD values of positive cells for the protein 
expression of OPG in a concentration-dependent manner 
(Figure 6A, B, and Figure 8A). 10-8 mol/L geraniin showed 
similar capacity for up-regulating the protein expression 
of OPG compared with alendronate. As presented in 
Figure 6C, D, and Figure 8B, no significant differences 
were shown in IOD and MOD values of positive cells 
for OPG mRNA expression between the control and 
geraniin groups (10-10 and 10-11 mol/L). Compared with 
the control and geraniin groups (10-10 and 10-11 mol/L), 
10-8 and 10-9mol/L geraniin and alendronate, however, 
significantly increased IOD and MOD values of positive 
cells for mRNA expression of OPG.
In contrast, there was no significant difference in 
MOD values of protein expression in RANKL positive 
cells between the control and geraniin (10-10 and 10-11 
mol/L) groups and IOD between the control and geraniin 
groups (10-11 mol/L)( Figure 7A, B, and Figure 9A). In 
comparison, geraniin (10-9 and10-8 mol/L) decreased IOD 
and MOD values of positive cells for RANKL protein 
FIGURE 4 - Comparison of mOC between mechanical and inductive procedure by TRAP staining (× 400). (A) Mechanical method 
for 3 d. (B) Inductive method for 4 d. (C) Inductive method 7 d. (D) Inductive method for 12 d. (E) Inductive method for 15 d.
FIGURE 5 - Effects of geraniin on bone resorption in OLC-OB co-culture system. Geraniin (10-11-10-8 mol/L) concentration-
dependently inhibited the resorption areas (A) and the number of resorption pits (B) per bone slice. Values are mean ± S.D. aP < 0.05, 
bP < 0.01 versus OLC group, cP < 0.05, dP < 0.01 versus OLC+OB group, e P < 0.05, f P < 0.01 versus between medicated group 
and alendronate group.
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expression in a concentration-dependent manner. 10-8 
mol/L geraniin also showed similar capacity for down-
regulation of RANKL protein expression compared with 
alendronate. As shown in Figure 7C, D and Figure 9B, 
there were no significant differences in IOD and MOD 
values of mRNA expression in RANKL positive cells 
between the control and geraniin groups (10-10 and 10-11 
mol/L). Compared with the control and geraniin groups 
(10-10 and 10-11 mol/L), 10-8 and 10-9mol/L geraniin and 
alendronate, however, significantly increased IOD and 
MOD values of positive cells for mRNA expression of 
RANKL. 10-8 mol/L geraniin also showed a similar ability 
compared with alendronate.
DISCUSSION
Bone remodelling is a continuous physiological 
process that occurs in adult skeleton in which bone 
resorption is followed by new bone formation. Bone 
cells that are responsible for this coupled process include 
bone-resorbing cells (osteoclasts, which are derived 
from haematopoietic cells of the monocyte/macrophage 
lineage) and bone-forming cells (osteoblasts, which are of 
mesenchymal origin).
RANKL/RANK/OPG system is one of the most 
important signal transduction pathways in the process of 
osteoclastic differentiation in recent years (Jules, Ashley, 
Feng, 2010). Osteoclasts play a key role in bone remodeling, 
and bone resorption through the binding of RANKL to its 
receptor-RANK, on the surface of pre-osteoclast cells. On 
the other hand, osteoblasts secrete a soluble decoy receptor 
(osteoprotegerin) that blocks RANK/RANKL interaction 
by binding to RANKL and thus, prevents the differentiation 
and activation of osteoclasts (Kiechl et al., 2006; Trouvin, 
Goeb, 2010). The ratio of these products, therefore, 
may modulate the ability of osteoblasts to stimulate the 
differentiation and activation of osteoclasts, as well as the 
degree of bone resorption (Eghbali-Fatourechi et al., 2003). 
It is of great interest that new and effective drug reducing 
the number and activity of osteoclasts, simultaneously 
increasing the number and activity of osteoblasts, may be 
designed to treat osteoporosis.
In our preliminary studies, we found that geraniin 
has an inhibitory effect on bone resorption only by 
FIGURE 6 - Effect of geraniin on protein and mRNA expression of OPG in osteoblasts. Geraniin (10-11 to 10-8 mol/L) increased 
MOD (A) and IOD (B) values of OPG protein expression in positive cells. Geraniin (10-11 to 10-8 mol/L) concentration-dependently 
increased MOD (C) and IOD (D) values of OPG mRNA expression in positive cells. Values are mean ± S.D. aP < 0.05, bP < 0.01 
versus control group, cP < 0.05, dP < 0.01 versus alendronate group, eP < 0.05 versus between geraniin (10-11 to10-8 mol/L) groups. 
One-way ANOVA followed by Student’s t-test.
X. Zhang, R. Yang, J. Long, B. He, Y. Zhang, T. Fu, Z. Shen, P. Chen
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osteoclasts in vitro (He et al., 2013). And in this study, 
we also found that geraniin has an inhibitory effect on 
bone resorption through regulating the proliferation and 
differentiation of the osteoblasts in vitro. 
The morphology of MC3T3-E1, through primary 
culture, is similar to osteoblasts. The higher activity 
of alkaline phosphatase (ALP) and the ability of 
mineralization reflect the two typical characteristics of 
differentiation and maturation of osteoblasts in vitro. In this 
study, the positive rate of ALP staining of MC3T3-E1 cells 
was more than 94%, and with the times of cell passages 
increasing, the positive rate of ALP was not decreased, 
indicating that multiple passage of the cells shows not 
significantly influence on the ability to secret alkaline 
phosphatase, and also suggesting that the obtained cells 
were mature osteoblasts. Thus, MC3T3-E1 can replace 
the primary cultured osteoblast as the cells for our further 
study. 10-12 - 10-9 mol/L geraniin significantly stimulated 
the proliferation of osteoblasts in a concentration 
dependent manner, while 10-6 mol/L geraniin inhibited 
the proliferation of osteoblasts. It is suggested that the 
FIGURE 7 - Effect of geraniin on protein and mRNA expression of RANKL in osteoblasts. Geraniin (10-11 to 10-8 mol/L) 
concentration-dependently decreased IOD (A) and MOD (B) values of RANKL protein expression in positive cells. Geraniin (10-11 
to 10-8 mol/L) concentration-dependently decreased MOD (C) and IOD (D) values of RANKL mRNA expression in positive cells. 
aP < 0.05, bP < 0.01 versus control group, cP < 0.05, dP < 0.01 versus alendronate group, eP < 0.05 versus between geraniin (10-11 
to10-8 mol/L) groups. One-way ANOVA followed by Student’s t-test.
effects of geraniin on proliferation of osteoblasts show 
bi-directional nature.
RAW264.7 cells are the only osteoclast precursor 
cells and share an even deeper homology with MC3T3-E1 
cells (Sanchez-Fernandez et al., 2008). It is reported 
that RAW264.7 cells can express the marker gene of 
osteoclastic phenotype and shows the function of bone 
resorption (Walsh et al., 2003). In this study, OLCs were 
successfully induced from RAW264.7 by RANKL and 
M-CFS. The fusion index (FI), presented as the average 
number of mOC cultured in vitro, indicates the number of 
cells that participate in cell fusion and mOC formation. 
TRAP staining, morphological observation and formation 
of bone resorption lacunae have been used as the important 
and reliable method for identifying OC (Walsh et al., 
2003). Our results revealed that geraniin significantly 
decreased the number of mOC and pOC, and the inhibited 
osteoclast formation due to its suppressing the fusion of 
pOC into mOC.
In our study, OC, OB, and bovine bone slices were 
cultured together to observe the effect of geraniin on 
A novel effect of geraniin on OPG/RANKL signaling in osteoblasts
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FIGURE 8 - Representative images of immunocytochemistry 
staining for OPG protein expression (A) and  in situ 
hybridization staining for OPG mRNA expression(B). Geraniin 
(10-11-10-8 mol/L) increased IOD and MOD values of OPG 
mRNA and protein expression in positive cells.
FIGURE 9 - Representative images of immunocytochemistry 
staining for RANKL protein expression (A) and in situ 
hybridization staining for RANKL mRNA expression(B). 
Geraniin (10-11-10-8 mol/L) decreased IOD and MOD values of 
RANKL mRNA and protein expression in positive cells.
osteoclastic bone resorption in OC-OB co-culture system. 
The results showed that geraniin (10-10 to 10-8 mol/L) could 
decrease the resorptive area and the number of resorptive 
pits in a concentration-dependent manner, suggesting that 
geraniin has an inhibitory effect on bone resorption in this 
OC-OB co-cultured system.
As one of major signaling pathways, RANKL/
RANK/OPG is responsible for the bone resorption and 
osteogenesis through the interaction between osteoblasts 
and osteoclasts. The present study showed that geraniin 
decreases IOD and MOD of RANKL positive cells, while 
increased IOD and MOD of OPG, suggesting that geraniin 
can regulate the mRNA and protein expression of OPG/
RANKL.
CONCLUSION
Geraniin shows a bi-directional nature on the 
proliferation of MC3T3-E1, inhibits the proliferation and 
differentiation of osteoclasts, and suppresses osteoclastic 
bone absorption. Upregulating OPG expression and 
downregulating RANKL expression may be responsible 
for its modulating the signaling pathway of OPG/RANKL.
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